4//SEC Filing
Furiex Pharmaceuticals, Inc. 4
Accession 0001437749-14-003387
CIK 0001484478operating
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:47 PM ET
Size
9.2 KB
Accession
0001437749-14-003387
Insider Transaction Report
Form 4
Kaldor Stephen W
Director
Transactions
- Award
Common Stock
2014-02-28+3,580→ 7,160 total
Holdings
- 8,825
Stock Options (to buy)
Exercise: $13.45Exp: 2021-10-12→ Common Stock (8,825 underlying) - 17,500
Stock Options (to buy)
Exercise: $18.22Exp: 2022-05-24→ Common Stock (17,500 underlying) - 5,012
Stock Options (to buy)
Exercise: $13.94Exp: 2021-05-19→ Common Stock (5,012 underlying)
Footnotes (4)
- [F1]The restricted stock was awarded on 2/28/2014 and vests in its entirety on the earlier of 5/22/2015 or immediately prior to the 2015 Annual Stockholder meeting, provided that the Grantee is still at that time serving on the Company's Board of Directors.
- [F2]The options were awarded on 5/19/2011 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- [F3]The options were awarded on 10/12/2011 and vest and become exercisable in full on the earlier of 5/19/2012 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- [F4]The options were awarded on 5/24/2012 and vest and become exercisable in full on the earlier of 5/24/2013 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
Documents
Issuer
Furiex Pharmaceuticals, Inc.
CIK 0001484478
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001484478
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 6:47 PM ET
- Size
- 9.2 KB